A detailed history of Surience Private Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Surience Private Wealth LLC holds 27,979 shares of NVO stock, worth $3.67 Million. This represents 5.5% of its overall portfolio holdings.

Number of Shares
27,979
Previous 2,050 1264.83%
Holding current value
$3.67 Million
Previous $263,000 1418.25%
% of portfolio
5.5%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $3.18 Million - $3.81 Million
25,929 Added 1264.83%
27,979 $3.99 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $179,949 - $216,172
2,050 New
2,050 $212,000
Q1 2022

Apr 20, 2022

SELL
$93.1 - $112.54 $3.93 Million - $4.75 Million
-42,233 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$95.88 - $117.08 $4.05 Million - $4.94 Million
42,233 New
42,233 $4.73 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $296B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Surience Private Wealth LLC Portfolio

Follow Surience Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Surience Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Surience Private Wealth LLC with notifications on news.